Rebel's Edge with Jon & Pete Najarian

Rebel's Edge with Jon & Pete Najarian

By Market RebellionBusiness
Download on the App Store

Rebel's Edge with Jon & Pete Najarian episodes

  • What Happened with the LegalZoom CEO?
    Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks Nvidia making more moves to the upside, Illumina acquiring Fluent BioSciences, Legal Zoom swapping CEOs, and Lantheus scoring a Medicare approval. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about Dak Prescott's ankle, and NCAA football conferences. Stay on the cutting edge with Rebel's Edge.
    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
    30 min
  • Intel On A Hot Streak!
    Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Intel continuing its hot streak, Tempus AI landing a "buy"rating, Helen of Troy not looking as hot as she used to, and Arlo Technologies puts AI cameras in our homes, (and we love it). Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about Olympic basketball, and Dak Prescott. Stay on the cutting edge with Rebel's Edge.
    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
    29 min
  • Intel VS Taiwan Semiconductor, and Leading the AI Pack
    Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Intel's AI success in the shadow of Taiwan Semiconductor, Corning riding the AI wave via optical glass, and Morphic Holdings getting gobbled up by Eli Lilly. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about the MLB All Star Game, and NFL training camp. Stay on the cutting edge with Rebel's Edge.
    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
    32 min
  • Biden Calls for Cheaper Ozempic
    Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Novo Nordisk biggest loser day after Biden calls for cheaper Ozempic, Barry Diller's bid to take control of Paramount Global, Tesla spiking on higher-than-expected EV deliveries, and Ardelyx backing off from a new treatment use-case. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about the Celtics payroll and the Atlanta Falcons prospects for the coming season. Stay on the cutting edge with Rebel's Edge.
    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
    27 min
  • Roaring Kitty Strikes Again
    Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Roaring Kitty followers getting burned, Bitcoin stocks enjoying a strong season, Nano Nuclear in a strong position to help meet energy needs, and Boeing buying Spirit AeroSystems. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about the NBA draft and the Indiana Fever. Stay on the cutting edge with Rebel's Edge.
    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
    34 min
  • Micron - An AI Cautionary Tale
    Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Micron dropping on guidance, Levi Straus dipping on a big miss, Walgreens considering store closures, and AeroVironment struggling in the military drone space. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about the NBA draft and Olympic gymnastics. Stay on the cutting edge with Rebel's Edge.
    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
    33 min
  • VW + Rivian - The Tesla Killer?
    Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Rivian partnering with VW on a plan that could take on Tesla, FedEx crushing estimates, Whirlpool fielding a takeover bid, and General Mills crying in their Cheerios. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about the NBA draft and QB battles in NFL spring training. Stay on the cutting edge with Rebel's Edge.
    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
    28 min
  • Ozempic and the Most Valuable Company In Europe
    Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Novo Nordisk riding Ozempic's success to "most valuable company" status in Europe, Nvidia dropping behind Apple and Microsoft in terms of market cap, DJT rallying in the run up to the presidential debate, and Carnival Cruise reporting smooth sailing. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about the Florida Panthers winning the Stanley Cup in game 7 against the Oilers, and the college World Series. Stay on the cutting edge with Rebel's Edge.
    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
    32 min
  • The Nvidia Horror Show - Who's Still Bullish?
    Join Pete Najarian and Marc LoPresti on today's episode of Rebel's Edge as they discuss stocks including UOA in Alnylam Pharmaceuticals, Affirm recovering from a dip, ResMed facing a potential CPAP killer, and Nvidia bulls get an opportunity from a sudden sell off. Gain a deeper understanding of these stocks as Pete and Marc share their perspectives, potential growth prospects, and market predictions. They also talk about game 7 of the Stanley Cup playoffs, and Pete's top 3 Olympic events. Stay on the cutting edge with Rebel's Edge.
    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
    27 min
  • The New AI Darling
    Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Autodesk getting shaken up by activist investor, Starboard Value, Best Buy leading their sector, Broadcom making waves as the new darling of AI, and AST Spacemobile seeking to offer 100% geographical coverage in the continental US. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about NFL tampering and corporate sponsors for NCAA divisions. Stay on the cutting edge with Rebel's Edge.
    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
    33 min

About Rebel's Edge with Jon & Pete Najarian

From the publisher's feed

Jon & Pete Najarian come together four days a week to talk market movement, unusual activity, sports and more!